BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23260012)

  • 21. Complex landscapes of somatic rearrangement in human breast cancer genomes.
    Stephens PJ; McBride DJ; Lin ML; Varela I; Pleasance ED; Simpson JT; Stebbings LA; Leroy C; Edkins S; Mudie LJ; Greenman CD; Jia M; Latimer C; Teague JW; Lau KW; Burton J; Quail MA; Swerdlow H; Churcher C; Natrajan R; Sieuwerts AM; Martens JW; Silver DP; Langerød A; Russnes HE; Foekens JA; Reis-Filho JS; van 't Veer L; Richardson AL; Børresen-Dale AL; Campbell PJ; Futreal PA; Stratton MR
    Nature; 2009 Dec; 462(7276):1005-10. PubMed ID: 20033038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RWCFusion: identifying phenotype-specific cancer driver gene fusions based on fusion pair random walk scoring method.
    Zhao J; Li X; Yao Q; Li M; Zhang J; Ai B; Liu W; Wang Q; Feng C; Liu Y; Bai X; Song C; Li S; Li E; Xu L; Li C
    Oncotarget; 2016 Sep; 7(38):61054-61068. PubMed ID: 27506935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FusionMap: detecting fusion genes from next-generation sequencing data at base-pair resolution.
    Ge H; Liu K; Juan T; Fang F; Newman M; Hoeck W
    Bioinformatics; 2011 Jul; 27(14):1922-8. PubMed ID: 21593131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent read-through fusion transcripts in breast cancer.
    Varley KE; Gertz J; Roberts BS; Davis NS; Bowling KM; Kirby MK; Nesmith AS; Oliver PG; Grizzle WE; Forero A; Buchsbaum DJ; LoBuglio AF; Myers RM
    Breast Cancer Res Treat; 2014 Jul; 146(2):287-97. PubMed ID: 24929677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative genomic analysis of primary tumors and metastases in breast cancer.
    Bertucci F; Finetti P; Guille A; Adélaïde J; Garnier S; Carbuccia N; Monneur A; Charafe-Jauffret E; Goncalves A; Viens P; Birnbaum D; Chaffanet M
    Oncotarget; 2016 May; 7(19):27208-19. PubMed ID: 27028851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization.
    Jönsson G; Staaf J; Olsson E; Heidenblad M; Vallon-Christersson J; Osoegawa K; de Jong P; Oredsson S; Ringnér M; Höglund M; Borg A
    Genes Chromosomes Cancer; 2007 Jun; 46(6):543-58. PubMed ID: 17334996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide mapping and characterization of hypomethylated sites in human tissues and breast cancer cell lines.
    Shann YJ; Cheng C; Chiao CH; Chen DT; Li PH; Hsu MT
    Genome Res; 2008 May; 18(5):791-801. PubMed ID: 18256232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decoding the fine-scale structure of a breast cancer genome and transcriptome.
    Volik S; Raphael BJ; Huang G; Stratton MR; Bignel G; Murnane J; Brebner JH; Bajsarowicz K; Paris PL; Tao Q; Kowbel D; Lapuk A; Shagin DA; Shagina IA; Gray JW; Cheng JF; de Jong PJ; Pevzner P; Collins C
    Genome Res; 2006 Mar; 16(3):394-404. PubMed ID: 16461635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breakpoint mapping by next generation sequencing reveals causative gene disruption in patients carrying apparently balanced chromosome rearrangements with intellectual deficiency and/or congenital malformations.
    Schluth-Bolard C; Labalme A; Cordier MP; Till M; Nadeau G; Tevissen H; Lesca G; Boutry-Kryza N; Rossignol S; Rocas D; Dubruc E; Edery P; Sanlaville D
    J Med Genet; 2013 Mar; 50(3):144-50. PubMed ID: 23315544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromosome-breakage genomic instability and chromothripsis in breast cancer.
    Przybytkowski E; Lenkiewicz E; Barrett MT; Klein K; Nabavi S; Greenwood CM; Basik M
    BMC Genomics; 2014 Jul; 15(1):579. PubMed ID: 25011954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular genetic characterization of the EWS/ATF1 fusion gene in clear cell sarcoma of tendons and aponeuroses.
    Panagopoulos I; Mertens F; Dêbiec-Rychter M; Isaksson M; Limon J; Kardas I; Domanski HA; Sciot R; Perek D; Crnalic S; Larsson O; Mandahl N
    Int J Cancer; 2002 Jun; 99(4):560-7. PubMed ID: 11992546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular cytogenetic analysis of a nontumorigenic human breast epithelial cell line that eventually turns tumorigenic: validation of an analytical approach combining karyotyping, comparative genomic hybridization, chromosome painting, and single-locus fluorescence in situ hybridization.
    Nielsen KV; Niebuhr E; Ejlertsen B; Holstebroe S; Madsen MW; Briand P; Mouridsen HT; Bolund L
    Genes Chromosomes Cancer; 1997 Sep; 20(1):30-7. PubMed ID: 9290951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatic structural rearrangements in genetically engineered mouse mammary tumors.
    Varela I; Klijn C; Stephens PJ; Mudie LJ; Stebbings L; Galappaththige D; van der Gulden H; Schut E; Klarenbeek S; Campbell PJ; Wessels LF; Stratton MR; Jonkers J; Futreal PA; Adams DJ
    Genome Biol; 2010; 11(10):R100. PubMed ID: 20942901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of fusion genes in breast cancer by paired-end RNA-sequencing.
    Edgren H; Murumagi A; Kangaspeska S; Nicorici D; Hongisto V; Kleivi K; Rye IH; Nyberg S; Wolf M; Borresen-Dale AL; Kallioniemi O
    Genome Biol; 2011; 12(1):R6. PubMed ID: 21247443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-range massively parallel mate pair sequencing detects distinct mutations and similar patterns of structural mutability in two breast cancer cell lines.
    Hampton OA; Koriabine M; Miller CA; Coarfa C; Li J; Den Hollander P; Schoenherr C; Carbone L; Nefedov M; Ten Hallers BF; Lee AV; De Jong PJ; Milosavljevic A
    Cancer Genet; 2011 Aug; 204(8):447-57. PubMed ID: 21962895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterising chromosome rearrangements: recent technical advances in molecular cytogenetics.
    Le Scouarnec S; Gribble SM
    Heredity (Edinb); 2012 Jan; 108(1):75-85. PubMed ID: 22086080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An integrated genomic analysis of Tudor domain-containing proteins identifies PHD finger protein 20-like 1 (PHF20L1) as a candidate oncogene in breast cancer.
    Jiang Y; Liu L; Shan W; Yang ZQ
    Mol Oncol; 2016 Feb; 10(2):292-302. PubMed ID: 26588862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detecting and visualizing gene fusions.
    Supper J; Gugenmus C; Wollnik J; Drueke T; Scherf M; Hahn A; Grote K; Bretschneider N; Klocke B; Zinser C; Cartharius K; Seifert M
    Methods; 2013 Jan; 59(1):S24-8. PubMed ID: 23036331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic hotspots but few recurrent fusion genes in breast cancer.
    Fimereli D; Fumagalli D; Brown D; Gacquer D; Rothé F; Salgado R; Larsimont D; Sotiriou C; Detours V
    Genes Chromosomes Cancer; 2018 Jul; 57(7):331-338. PubMed ID: 29436103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer.
    Han B; Mehra R; Dhanasekaran SM; Yu J; Menon A; Lonigro RJ; Wang X; Gong Y; Wang L; Shankar S; Laxman B; Shah RB; Varambally S; Palanisamy N; Tomlins SA; Kumar-Sinha C; Chinnaiyan AM
    Cancer Res; 2008 Sep; 68(18):7629-37. PubMed ID: 18794152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.